Mark Massaro
Stock Analyst at BTIG
(4.49)
# 346
Out of 5,005 analysts
145
Total ratings
52.38%
Success rate
21.71%
Average return
Main Sectors:
Stocks Rated by Mark Massaro
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $70 → $80 | $62.84 | +27.31% | 5 | Sep 25, 2025 | |
| CDNA CareDx | Reiterates: Buy | $22 | $15.19 | +44.83% | 4 | Sep 23, 2025 | |
| LUCD Lucid Diagnostics | Reiterates: Buy | $2.5 | $1.04 | +140.38% | 4 | Sep 10, 2025 | |
| DNA Ginkgo Bioworks Holdings | Maintains: Sell | $6 → $9 | $16.14 | -44.24% | 7 | Aug 25, 2025 | |
| TEM Tempus AI | Maintains: Buy | $75 → $85 | $91.66 | -7.27% | 3 | Aug 20, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $65 → $60 | $56.72 | +5.78% | 17 | Aug 12, 2025 | |
| MXCT MaxCyte | Downgrades: Neutral | n/a | $1.71 | - | 4 | Aug 11, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Buy | $8 → $9 | $14.38 | -37.41% | 5 | Dec 18, 2024 | |
| BNGO Bionano Genomics | Downgrades: Neutral | n/a | $1.92 | - | 8 | Sep 10, 2024 | |
| PSNL Personalis | Maintains: Buy | $5.5 → $7 | $7.34 | -4.63% | 1 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 → $225 | $146.42 | +53.67% | 2 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $135 | $167.35 | -19.33% | 13 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $45 | $118.26 | -61.95% | 4 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $580 | $631.19 | -8.11% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $21 | $9.10 | +130.77% | 4 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.64 | - | 1 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $4.81 | +66.32% | 8 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $8 | $4.40 | +81.82% | 2 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $30 | $22.72 | +32.04% | 4 | Jun 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $10.96 | -54.38% | 3 | Mar 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.57 | - | 1 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $350 → $300 | $102.12 | +193.77% | 6 | Sep 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $52 → $50 | $68.22 | -26.71% | 9 | Nov 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $108 → $112 | $179.33 | -37.55% | 10 | Jul 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $155 → $165 | $276.94 | -40.42% | 10 | May 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $78 → $80 | $29.98 | +166.84% | 9 | Sep 10, 2018 |
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $70 → $80
Current: $62.84
Upside: +27.31%
CareDx
Sep 23, 2025
Reiterates: Buy
Price Target: $22
Current: $15.19
Upside: +44.83%
Lucid Diagnostics
Sep 10, 2025
Reiterates: Buy
Price Target: $2.5
Current: $1.04
Upside: +140.38%
Ginkgo Bioworks Holdings
Aug 25, 2025
Maintains: Sell
Price Target: $6 → $9
Current: $16.14
Upside: -44.24%
Tempus AI
Aug 20, 2025
Maintains: Buy
Price Target: $75 → $85
Current: $91.66
Upside: -7.27%
Exact Sciences
Aug 12, 2025
Maintains: Buy
Price Target: $65 → $60
Current: $56.72
Upside: +5.78%
MaxCyte
Aug 11, 2025
Downgrades: Neutral
Price Target: n/a
Current: $1.71
Upside: -
Adaptive Biotechnologies
Dec 18, 2024
Maintains: Buy
Price Target: $8 → $9
Current: $14.38
Upside: -37.41%
Bionano Genomics
Sep 10, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.92
Upside: -
Personalis
Aug 16, 2024
Maintains: Buy
Price Target: $5.5 → $7
Current: $7.34
Upside: -4.63%
Aug 12, 2024
Maintains: Buy
Price Target: $220 → $225
Current: $146.42
Upside: +53.67%
Aug 9, 2024
Maintains: Buy
Price Target: $125 → $135
Current: $167.35
Upside: -19.33%
Jul 31, 2024
Maintains: Buy
Price Target: $35 → $45
Current: $118.26
Upside: -61.95%
Jul 25, 2024
Initiates: Buy
Price Target: $580
Current: $631.19
Upside: -8.11%
May 2, 2024
Maintains: Buy
Price Target: $23 → $21
Current: $9.10
Upside: +130.77%
Mar 12, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.64
Upside: -
Mar 7, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $4.81
Upside: +66.32%
Mar 6, 2024
Maintains: Buy
Price Target: $7 → $8
Current: $4.40
Upside: +81.82%
Jun 15, 2023
Maintains: Buy
Price Target: $38 → $30
Current: $22.72
Upside: +32.04%
Mar 22, 2023
Maintains: Buy
Price Target: $6 → $5
Current: $10.96
Upside: -54.38%
Jan 20, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.57
Upside: -
Sep 22, 2020
Maintains: Hold
Price Target: $350 → $300
Current: $102.12
Upside: +193.77%
Nov 11, 2019
Maintains: Hold
Price Target: $52 → $50
Current: $68.22
Upside: -26.71%
Jul 24, 2019
Maintains: Buy
Price Target: $108 → $112
Current: $179.33
Upside: -37.55%
May 2, 2019
Maintains: Hold
Price Target: $155 → $165
Current: $276.94
Upside: -40.42%
Sep 10, 2018
Maintains: Buy
Price Target: $78 → $80
Current: $29.98
Upside: +166.84%